FDA officials argue in favor of randomized trials for Ebola drugs
This article was originally published in SRA
Executive Summary
Two officials from the US Food and Drug Administration on 5 November argued that randomized controlled trials (RCT) are necessary to prove the safety and effectiveness of the experimental Ebola drugs that are currently being developed.